Document is current
Any future updates will be listed below
-
Authors
Barrett, Stephen L.
Boyd, Bailey
DuCasse, Sequioa
Nassier, Wajdi
Mitchell, Nia
Nagra, Artinder P.
Dalmau-Pastor, Miki
Yamasaki, Dwayne S.
Nickerson, Scott
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 17 October 2024
First Online: 23 October 2024
Declarations
:
: Ethics approval for this study has been obtained from the Institutional Review Board of Kennesaw State University under the FDA and DHHS (OHRP) designation of category 1a - Clinical study of drugs and medical devices for which investigational new drug application is not required.
: Not applicable.
: The authors declare no competing interests.
: Informed consent was obtained from all subjects before their participation in the study. Participants received clear and comprehensive information regarding the study’s purpose, procedures, potential risks and benefits, confidentiality measures, and their right to withdraw at any time without consequences.
